Plasma fetuin-A levels and the risk of type 2 diabetes

Nonalcoholic Fatty Liver Disease

Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228 · see citing works

Type 2 diabetes: principles of pathogenesis and therapy

Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662 · see citing works

A Potential Decline in Life Expectancy in the United States in the 21st Century

Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612 · see citing works

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086 · see citing works

A Potential Decline in Life Expectancy in the United States in the 21st Century

Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J. E., Carnes, B. A., Brody, J. A., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944 · see citing works

Nonalcoholic fatty liver disease

Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,652 · see citing works

A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials

Prentice, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,444 · see citing works

Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · see citing works

Advances in Male Contraception

Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134 · see citing works

Adiponectin and protection against type 2 diabetes mellitus

Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120 · see citing works

Adiponectin and development of type 2 diabetes in the Pima Indian population

Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094 · see citing works

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

Ketteler, M., Bongartz, P., Westenfeld, R., Wildberger, J. E., Mahnken, A. H., Böhm, R. O. B., Metzger, T., Wanner, C., Jahnen‐Dechent, W., & Floege, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12710-9 · Cited by 909 · see citing works

Fatty Liver

Kotronen, A., & Yki‐Järvinen, H. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 793 · see citing works

Analysis of Case-Cohort Designs

Barlow, W. E., Ichikawa, L., Rosner, D., & Izumi, S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00102-x · Cited by 682 · see citing works

Genomewide Search for Type 2 Diabetes–Susceptibility Genes in French Whites: Evidence for a Novel Susceptibility Locus for Early-Onset Diabetes on Chromosome 3q27-qter and Independent Replication of a Type 2–Diabetes Locus on Chromosome 1q21–q24

Vionnet, N., Hani, E. H., Dupont, S., Gallina, S., Francke, S., Dotte, S., de Matos, F., Durand, E., Leprêtre, F., Lecœur, C., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316887 · Cited by 679 · see citing works

Adipose Tissue-Derived Factors: Impact on Health and Disease

Trujillo, M. E., & Scherer, P. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0033 · Cited by 611 · see citing works

α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans

Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Kröber, S. M., Machicao, F. E., Fritsche, A., & Häring, H. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1938 · Cited by 475 · see citing works

The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity

Gerich, J. E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0338 · Cited by 444 · see citing works

Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene

Mathews, S. T., Singh, G. P., Ranalletta, M., Cintrón, V. J., Qiang, X., Goustin, A. S., Jen, K. C., Charron, M. J., Jahnen‐Dechent, W., & Grunberger, G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2450 · Cited by 343 · see citing works

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

Auberger, P., Falquerho, L., Contreres, J. O., Pagès, G., Cam, G. L., Rossi, B., & Cam, A. L. (1989) · Cell · doi:10.1016/0092-8674(89)90098-6 · Cited by 321 · see citing works

Association Between Human Fetuin-A and the Metabolic Syndrome

Ix, J. H., Shlipak, M. G., Brandenburg, V. M., Ali, S., Ketteler, M., & Whooley, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.588723 · Cited by 316 · see citing works

Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A

Denecke, B., Gräber, S., Schäfer, C., Heiss, A., Wöltje, M., & Jahnen‐Dechent, W. (2003) · Biochemical Journal · doi:10.1042/bj20030676 · Cited by 287 · see citing works

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001765 · Cited by 282 · see citing works

EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases

Boeing, H., Wahrendorf, J., & Becker, N. (1999) · Annals of Nutrition and Metabolism · doi:10.1159/000012786 · Cited by 256 · see citing works

Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men

Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238 · see citing works

Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects

Mori, K., Emoto, M., Yokoyama, H., Araki, T., Teramura, M., Koyama, H., Shoji, T., Inaba, M., & Nishizawà, Y. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1484 · Cited by 213 · see citing works

α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor

Mathews, S. T. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00237-9 · Cited by 179 · see citing works

The nucleotide and partial amino acid sequences of rat fetuin

Rauth, G., Poeschke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Haasemann, M., Jahnen‐Dechent, W., et al. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16663.x · Cited by 134 · see citing works

Design Options for Molecular Epidemiology Research within Cohort Studies

Rundle, A. G., Vineis, P., & Ahsan, H. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0860 · Cited by 117 · see citing works

Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

Schulze, M. B., Schulz, M., Heidemann, C., Schienkiewitz, A., Hoffmann, K., & Boeing, H. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507853360 · Cited by 108 · see citing works

Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity

Lin, X., Braymer, H. D., Bray, G. A., & York, D. A. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00250-1 · Cited by 79 · see citing works

A Synonymous Coding Polymorphism in the α2-Heremans-Schmid Glycoprotein Gene Is Associated With Type 2 Diabetes in French Caucasians

Siddiq, A., Leprêtre, F., Herçberg, S., Froguel, P., & Gibson, F. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2477 · Cited by 75 · see citing works

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach

Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988 · see citing works

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · see citing works

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R. A., Bugianesi, E., & Gastaldelli, A. (2013) · Nutrients · doi:10.3390/nu5051544 · Cited by 824 · see citing works

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 751 · see citing works

Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications

Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 645 · see citing works

Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance

Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631 · see citing works

Causes and Metabolic Consequences of Fatty Liver

Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 529 · see citing works

Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases

Bennett, J. M., Reeves, G., Billman, G. E., & Sturmberg, J. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00316 · Cited by 531 · see citing works

The role of hepatokines in metabolism

Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · see citing works

The impact of insulin resistance on the kidney and vasculature

Artunç, F., Schleicher, E. D., Weigert, C., Fritsche, A., Stefan, N., & Häring, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 474 · see citing works

Metabolic syndrome

Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463 · see citing works

Fetuin-A Regulation of Calcified Matrix Metabolism

Jahnen‐Dechent, W., Heiss, A., Schäfer, C., & Ketteler, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.234260 · Cited by 386 · see citing works

Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease

Ix, J. H., & Sharma, K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009080820 · Cited by 351 · see citing works

The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification

Kay, A. M., Simpson, C. L., & Stewart, J. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6809703 · Cited by 348 · see citing works

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

Weikert, C., Stefan, N., Schulze, M. B., Pischon, T., Berger, K., Joost, H., Häring, H., Boeing, H., & Fritsche, A. (2008) · Circulation · doi:10.1161/circulationaha.108.814418 · Cited by 310 · see citing works

TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation

Velloso, L. A., Folli, F. B., & Saad, M. J. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1100 · Cited by 314 · see citing works

Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene

Kantartzis, K., Peter, A., Machicao, F. E., Machann, J., Wagner, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., Häring, H., et al. (2009) · Diabetes · doi:10.2337/db09-0279 · Cited by 299 · see citing works

The role of hepatokines in NAFLD

Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 282 · see citing works

Cytokines and abnormal glucose and lipid metabolism

Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282 · see citing works

The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review

Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · see citing works

Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots

HOCKING, S. L., Samocha‐Bonet, D., Milner, K., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 281 · see citing works

Hepatokines and metabolism: Deciphering communication from the liver

Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252 · see citing works

Metabolic adaptation in obesity and type ii diabetes: myokines, adipokines and hepatokines

Oh, K.-J., Lee, D., Kim, W., Han, B., Lee, S., & Bae, K.-H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010008 · Cited by 210 · see citing works

Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss

Reinehr, T., & Roth, C. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1505 · Cited by 208 · see citing works

Liver and diabetes. A vicious circle

Loria, P., Lonardo, A., & Anania, F. A. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01031.x · Cited by 206 · see citing works

Characterisation of matrix vesicles in skeletal and soft tissue mineralisation

Cui, L., Houston, D. A., Farquharson, C., & MacRae, V. E. (2016) · Bone · doi:10.1016/j.bone.2016.04.007 · Cited by 187 · see citing works

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

Hotta, K., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Chayama, K., Nakajima, A., Nakao, K., & Sekine, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-172 · Cited by 172 · see citing works

The Metabolically Benign and Malignant Fatty Liver

Stefan, N., & Häring, H. (2011) · Diabetes · doi:10.2337/db11-0231 · Cited by 172 · see citing works

Metabolic interplay between white, beige, brown adipocytes and the liver

Scheja, L., & Heeren, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.025 · Cited by 171 · see citing works

NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance

Dasgupta, S., Bhattacharya, S., Biswas, A., Majumdar, S. S., Mukhopadhyay, S., Ray, S., & Bhattacharya, S. (2010) · Biochemical Journal · doi:10.1042/bj20100330 · Cited by 168 · see citing works

Insulin Resistance in Patients with Chronic Kidney Disease

Liao, M.-T., Sung, C., Hung, K.-C., Wu, C., Lo, L., & Lu, K. (2012) · BioMed Research International · doi:10.1155/2012/691369 · Cited by 165 · see citing works

Fetuin-A: A novel link between obesity and related complications

Trepanowski, J. F., Mey, J., & Varady, K. A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.203 · Cited by 161 · see citing works

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

Stefan, N., & Häring, H.-U. (2013) · Nature Medicine · doi:10.1038/nm.3116 · Cited by 160 · see citing works

Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in Humans

Peter, A., Kantartzis, K., Machann, J., Schick, F., Staiger, H., Machicao, F. E., Schleicher, E. D., Fritsche, A., Häring, H., & Stefan, N. (2010) · Diabetes · doi:10.2337/db10-0179 · Cited by 156 · see citing works

The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Khalili, L., Alipour, B., Jafarabadi, M. A., Faraji, I., Hassanalilou, T., Abbasi, M. M., Vaghef‐Mehrabany, E., & Sani, M. A. (2018) · Iranian Biomedical Journal · doi:10.29252/ibj.23.1.68 · Cited by 153 · see citing works

The structure, biosynthesis, and biological roles of fetuin-A: A review

Abebe, E. C., Muche, Z. T., Mariam, A. B. T., Ayele, T. M., Agidew, M. M., Azezew, M. T., Zewde, E. A., Dejenie, T. A., & Mengstie, M. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.945287 · Cited by 151 · see citing works

The impact of liver fat vs visceral fat in determining categories of prediabetes

Kantartzis, K., Machann, J., Schick, F., Fritsche, A., Häring, H., & Stefan, N. (2010) · Diabetologia · doi:10.1007/s00125-010-1663-6 · Cited by 146 · see citing works

Use of Multiple Metabolic and Genetic Markers to Improve the Prediction of Type 2 Diabetes: the EPIC-Potsdam Study

Schulze, M. B., Weikert, C., Pischon, T., Bergmann, M. M., Al‐Hasani, H., Schleicher, E. D., Fritsche, A., Häring, H., Boeing, H., & Joost, H. (2009) · Diabetes Care · doi:10.2337/dc09-0197 · Cited by 141 · see citing works

Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals

Badoud, F., Perreault, M., Zulyniak, M. A., & Mutch, D. M. (2014) · The FASEB Journal · doi:10.1096/fj.14-263913 · Cited by 127 · see citing works

Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study

Montonen, J., Boeing, H., Steffen, A., Lehmann, R., Fritsche, A., Joost, H.-G., Schulze, M. B., & Pischon, T. (2012) · Diabetologia · doi:10.1007/s00125-012-2633-y · Cited by 124 · see citing works

Amino acids, lipid metabolites, and ferritin as potential mediators linking red meat consumption to type 2 diabetes

Wittenbecher, C., Mühlenbruch, K., Kröger, J., Jacobs, S., Kuxhaus, O., Floegel, A., Fritsche, A., Pischon, T., Prehn, C., Adamski, J., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.099150 · Cited by 120 · see citing works

Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review

Bourebaba, L., & Marycz, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122033 · Cited by 123 · see citing works

Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis

Dietrich, S., Floegel, A., Troll, M., Kuhn, T. E., Rathmann, W., Peters, A., Sookthai, D., von Bergen�, M., Kaaks, R., Adamski, J., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw145 · Cited by 116 · see citing works

Breast-feeding and maternal risk of type 2 diabetes: a prospective study and meta-analysis

Jäger, S., Jacobs, S., Kröger, J., Fritsche, A., Schienkiewitz, A., Rubin, D., Boeing, H., & Schulze, M. B. (2014) · Diabetologia · doi:10.1007/s00125-014-3247-3 · Cited by 115 · see citing works

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

Brix, J. M., Stingl, H., Höllerl, F., Schernthaner, G.-H., Kopp, H.-P., & Schernthaner, G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0148 · Cited by 112 · see citing works

Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver

Lehmann, R., Franken, H., Dammeier, S., Rosenbaum, L., Kantartzis, K., Peter, A., Zell, A., Adam, P., Li, J., Xu, G., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1760 · Cited by 109 · see citing works

Advanced research on risk factors of type 2 diabetes

Bi, Y., Wang, T., Xu, M., Xu, Y., Li, M., Lu, J., Zhu, X., & Ning, G. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2352 · Cited by 107 · see citing works

Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism

Meneses, M. J., Silva, B. M., Sousa, M., Sá, R., Oliveira, P. F., & Alves, M. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710145753 · Cited by 109 · see citing works

Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived ‘Browning’ Factor Irisin, Determines Insulin Sensitivity

Staiger, H., Böhm, A., Scheler, M., Berti, L., Machann, J., Schick, F., Machicao, F. E., Fritsche, A., Stefan, N., Weigert, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061903 · Cited by 105 · see citing works

Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes

Eckel, N., Mühlenbruch, K., Meidtner, K., Boeing, H., Stefan, N., & Schulze, M. B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.009 · Cited by 104 · see citing works

The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance

Goustin, A. S., & Abou‐Samra, A. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.003 · Cited by 97 · see citing works

Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature

Dąbrowska, A. M., Tarach, J. S., Wojtysiak-Duma, B., & Duma, D. (2015) · Biomedical Papers · doi:10.5507/bp.2015.018 · Cited by 98 · see citing works

Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study

Fisher, E., Stefan, N., Saar, K., Drogan, D., Schulze, M. B., Fritsche, A., Joost, H., Häring, H., Hübner, N., Boeing, H., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.870410 · Cited by 97 · see citing works

Hepatokines as a Link between Obesity and Cardiovascular Diseases

Yoo, H. J., & Choi, K. M. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.10 · Cited by 94 · see citing works

Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations

Wolk, K., & Sabat, R. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9381-0 · Cited by 94 · see citing works

Plasma fetuin‐ A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease

Doğru, T., Genç, H., Tapan, S., Aslan, F., Erçin, C. N., Örs, F., Kara, M., Sertoğlu, E., Karslıoğlu, Y., Bağcı, S., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04460.x · Cited by 90 · see citing works

Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults

Jensen, M. K., Bartz, T. M., Mukamal, K. J., Djoussé, L., Kizer, J. R., Tracy, R. P., Zieman, S. J., Rimm, E. B., Siscovick, D. S., Shlipak, M. G., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1591 · Cited by 88 · see citing works

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.

Sun, Q., Cornelis, M. C., Manson, J. E., & Hu, F. B. (2012) · Diabetes · doi:10.2337/db12-0372 · Cited by 87 · see citing works

The Association of Fetuin-A With Cardiovascular Disease Mortality in Older Community-Dwelling Adults

Laughlin, G. A., Cummins, K. M., Wassel, C. L., Daniels, L. B., & Ix, J. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.038 · Cited by 88 · see citing works

Novel targets for potential therapeutic use in Diabetes mellitus

Dhankhar, S., Chauhan, S., Mehta, D. K., Nitika, Saini, K., Saini, M., Das, R., Gupta, S., & Gautam, V. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00983-5 · Cited by 86 · see citing works

Fetuin-A and the cardiovascular system

Mori, K., Emoto, M., & Inaba, M. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394317-0.00010-8 · Cited by 86 · see citing works

Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults

Song, A., Xu, M., Bi, Y., Xu, Y., Huang, Y., Li, M., Wang, T., Wu, Y., Liu, Y., Li, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019228 · Cited by 84 · see citing works

The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans

Peter, A., Kovářová, M., Staiger, H., Machann, J., Schick, F., Königsrainer, A., Königsrainer, I., Schleicher, E. D., Fritsche, A., Häring, H., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2017 · Cited by 82 · see citing works

Presence of Gallstones or Kidney Stones and Risk of Type 2 Diabetes

Weikert, C., Weikert, S., Schulze, M. B., Pischon, T., Fritsche, A., Bergmann, M. M., Willich, S. N., & Boeing, H. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp411 · Cited by 82 · see citing works

Melatonin improves insulin resistance and hepatic steatosis through attenuation of alpha‐2‐ HS ‐glycoprotein

Heo, J., Yoon, D. W., Yu, J. H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12493 · Cited by 80 · see citing works

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies

Stefan, N., Sun, Q., Fritsche, A., Machann, J., Schick, F., Gerst, F., Jeppesen, C., Joost, H., Hu, F. B., Boeing, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092238 · Cited by 80 · see citing works

New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms

Schäfer, S., Machicao, F. E., Fritsche, A., Häring, H., & Kantartzis, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70008-0 · Cited by 78 · see citing works

Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease

Zhang, L., Qu, X.-N., Sun, Z.-Y., & Zhang, Y. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.01.007 · Cited by 77 · see citing works

Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population

Reinehr, T., & Roth, C. L. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1110-5 · Cited by 77 · see citing works

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

Xu, Y., Xu, M., Bi, Y., Song, A., Huang, Y., Liu, Y., Wu, Y., Chen, Y., Wang, W., Li, X., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.020 · Cited by 76 · see citing works

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

Lorant, D., Grujicic, M., Höbaus, C., Brix, J., Höllerl, F., Schernthaner, G., Koppensteiner, R., & Schernthaner, G.-H. (2010) · Diabetes Care · doi:10.2337/dc10-0788 · Cited by 76 · see citing works

The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes

Guerra, S., & Gastaldelli, A. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.016 · Cited by 74 · see citing works

Implication of hepatokines in metabolic disorders and cardiovascular diseases

Jung, T. W., Yoo, H. J., & Choi, K. M. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.03.002 · Cited by 71 · see citing works

Association of Fetuin-A With Incident Diabetes Mellitus in Community-Living Older Adults

Ix, J. H., Biggs, M. L., Mukamal, K. J., Kizer, J. R., Zieman, S. J., Siscovick, D. S., Mozaffarian, D., Jensen, M. K., Nelson, L., Ruderman, N. B., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.072751 · Cited by 71 · see citing works

Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men

Ishibashi, A., Ikeda, Y., Ohguro, T., Kumon, Y., Yamanaka, S., Takata, H., Inoue, M., Suehiro, T., & Terada, Y. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3830 · Cited by 71 · see citing works

Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study , ,

Jacobs, S., Kröger, J., Floegel, A., Boeing, H., Drogan, D., Pischon, T., Fritsche, A., Prehn, C. P., Adamski, J., Isermann, B., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.080317 · Cited by 72 · see citing works

Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease

Malin, S. K., Mulya, A., Fealy, C. E., Haus, J. M., Pagadala, M. R., Scelsi, A. R., Huang, H., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00237.2013 · Cited by 68 · see citing works

Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES‐Reykjavik Study

Kim, L. J., Nalls, M. A., Eiríksdóttir, G., Sigurdsson, S. O., Launer, L. J., Koster, A., Chaves, P. H. M., Jónsdóttir, B., García, M., Gudnason, V. G., et al. (2010) · Obesity · doi:10.1038/oby.2010.291 · Cited by 69 · see citing works

Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study

Jäger, S., Jacobs, S., Kröger, J., Stefan, N., Fritsche, A., Weikert, C., Boeing, H., & Schulze, M. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124749 · Cited by 69 · see citing works

Endoplasmic Reticulum Stress Induces the Expression of Fetuin-A to Develop Insulin Resistance

Ou, H., Wu, H., Hung, H., Yang, Y., Wu, J., & Chang, C. (2012) · Endocrinology · doi:10.1210/en.2011-2043 · Cited by 69 · see citing works

Proinflammatory and Antiinflammatory Attributes of Fetu Iν-A: A Novel Hepatokine Modulating Cardiovascular and Glycemic Outcomes in Metabolic Syndrome

Mukhopadhyay, S., Mondal, S. A., Kumar, M., & Dutta, D. (2014) · Endocrine Practice · doi:10.4158/ep14421.ra · Cited by 69 · see citing works

Similar Albeit Not the Same: In-Depth Analysis of Proteoforms of Human Serum, Bovine Serum, and Recombinant Human Fetuin

Lin, Y., Franc, V., & Heck, A. J. R. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00318 · Cited by 67 · see citing works

Serum fetuin‐A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes

Ou, H., Yang, Y., Wu, H., Wu, J., Lu, F., & Chang, C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04070.x · Cited by 66 · see citing works

Role of fetuin-A in atherosclerosis associated with diabetic patients

Singh, M., Sharma, P. K., Garg, V. K., Mondal, S. C., Singh, A. K., & Kumar, N. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01561.x · Cited by 64 · see citing works

Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam study

Kröger, J., Jacobs, S., Jansen, E. H. J. M., Fritsche, A., Boeing, H., & Schulze, M. B. (2014) · Diabetologia · doi:10.1007/s00125-014-3421-7 · Cited by 64 · see citing works

Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis

Guo, V. Y., Cao, B., Cai, C. C., Cheng, K. K. Y., & Cheung, B. M. Y. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1068-9 · Cited by 63 · see citing works

High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population

Rittig, K., Thamer, C., Haupt, A., Machann, J., Peter, A., Balletshofer, B. M., Fritsche, A., Häring, H., & Stefan, N. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.018 · Cited by 63 · see citing works

Interaction between plasma fetuin‐A and free fatty acids predicts changes in insulin sensitivity in response to long‐term exercise

Lee-Ødegård, S., Norheim, F., Gulseth, H. L., Langleite, T. M., Kolnes, K. J., Tangen, D. S., Stadheim, H. K., Gilfillan, G. D., Holen, T., Birkeland, K. I., et al. (2017) · Physiological Reports · doi:10.14814/phy2.13183 · Cited by 59 · see citing works

Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects

Kim, S. S., Cho, H. J., Kim, H. J., Kang, D. R., Berry, J. R., Kim, J. H., Yang, M. J., Kim, S., Kim, S., Cheong, J. Y., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.12.018 · Cited by 62 · see citing works

Clinical implications of fetuin-A

Jirak, P., Stechemesser, L., Morè, E., Franzen, M., Topf, A., Mirna, M., Paar, V., Pistulli, R., Kretzschmar, D., Wernly, B., et al. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.12.003 · Cited by 62 · see citing works

Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells

Siegel-Axel, D. I., Ullrich, S., Stefan, N., Rittig, K., Gerst, F., Klingler, C., Schmidt, U., Schreiner, B., Randrianarisoa, E., Schaller, H., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3177-0 · Cited by 61 · see citing works

The Associations of Fetuin-A With Subclinical Cardiovascular Disease in Community-Dwelling Persons

Ix, J. H., Barrett-Connor, E. L., Wassel, C. L., Cummins, K. M., Bergstrom, J., Daniels, L. B., & Laughlin, G. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.035 · Cited by 61 · see citing works

The effects of caloric restriction on F etuin‐ A and cardiovascular risk factors in rats and humans: a randomized controlled trial

Choi, K. M., Han, K. A., Ahn, H. J., Lee, S. Y., Hwang, S. Y., Kim, B. C., Hong, H. C., Choi, H. Y., Yang, S. J., Yoo, H. J., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12076 · Cited by 60 · see citing works

Analysis of Calcifications in Patients with Coral Reef Aorta

Schlieper, G., Grotemeyer, D., Aretz, A., Schurgers, L. J., Krüger, T., Rehbein, H., Weirich, T. E., Westenfeld, R., Brandenburg, V. M., Eitner, F., et al. (2010) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2009.11.006 · Cited by 59 · see citing works

Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging

Ghosh, A. K., O’Brien, M., Mau, T., & Yung, R. L. (2017) · Aging · doi:10.18632/aging.101288 · Cited by 58 · see citing works

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes

Eraso, L. H., Ginwala, N., Qasim, A., Mehta, N. N., Dlugash, R., Kapoor, S. C., Schwartz, S. J., Schutta, M. H., Iqbal, N., Mohler, E. R., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1541 · Cited by 58 · see citing works

Hepatokines—A novel group of exercise factors

Weigert, C., Hoene, M., & Plomgaard, P. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2216-y · Cited by 57 · see citing works

Helicobacter pyloriinfection and liver diseases: Epidemiology and insights into pathogenesis

Okushin, K., Tsutsumi, T., Ikeuchi, K., Kado, A., Enooku, K., Fujinaga, H., Moriya, K., Yotsuyanagi, H., & Koike, K. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i32.3617 · Cited by 63 · see citing works

Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys.

Stefan, N., Artunc, F., Heyne, N., Machann, J., Schleicher, E., & Häring, H. (2016) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfu081 · Cited by 50 · see citing works

Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism

Bilgir, O., Bilgir, F., Calan, M., Calan, O. G., & Yuksel, A. (2015) · Clinics · doi:10.6061/clinics/2015(02)05 · Cited by 54 · see citing works

ORIGINAL ARTICLE Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes

Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H., Häring, H.-U., & Schulze, M. B. (2013)

Plasma Fetuin-A Levels and Risk of Type 2 Diabetes Mellitus in A Chinese Population: A Nested Case-Control Study

Wang, Y., Koh, W., Jensen, M. K., Yuan, J., & Pan, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0171 · Cited by 20 · see citing works

Fetuin-A and Incident Diabetes Mellitus in Older Persons

Ix, J. H. (2008) · JAMA · doi:10.1001/jama.300.2.182 · Cited by 267 · see citing works

The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies

Roshanzamir, F., Miraghajani, M. S., Rouhani, M. H., Mansourian, M., Ghiasvand, R., & Safavi, S. M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0697-8 · Cited by 49 · see citing works

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.

Sun, Q., Cornelis, M. C., Manson, J. E., & Hu, F. B. (2012) · Diabetes · doi:10.2337/db12-0372 · Cited by 87 · see citing works